No, not a new band. Just another twist in the whole Apotex coup story.
Canadian generic drugmaker Apotex, accused BMS of attempting to mislead US regulators about secret side-deals in a settlement to end patent litigation over blockbuster drug Plavix, according to court documents yesterday.
Apotex said it alerted the Federal Trade Commission to efforts by a senior BMS executive, Andrew Bodnar, allegedly to deceive the government about verbal agreements outside settlement provisions.
Source: FT
No comments:
Post a Comment